2020
DOI: 10.2217/pgs-2020-0066
|View full text |Cite
|
Sign up to set email alerts
|

The Inclusion of Health Data Standards in the Implementation of Pharmacogenomics Systems: A Scoping Review

Abstract: Background: Despite potential benefits, the practice of incorporating pharmacogenomics (PGx) results in clinical decisions has yet to diffuse widely. In this study, we conducted a review of recent discussions on data standards and interoperability with a focus on sharing PGx test results among health systems. Materials & methods: We conducted a literature search for PGx clinical decision support systems between 1 January 2012 and 31 January 2020. Thirty-two out of 727 articles were included for the final r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 67 publications
(70 reference statements)
0
10
0
Order By: Relevance
“…Another consideration for the app design is incorporating health information exchange, genomics data integration, complex analysis of patient clinical charts, and other 360 data integration. [16,[35][36][37][38][39] Early diagnosis of ADRD can also benefit disadvantaged populations, such as those with lower socioeconomic and health literacy. [40] Digital inclusion of diverse racial/ethnic disparities is limited and not well represented in existing ADRD research.…”
Section: Artificial Intelligence Can Helpmentioning
confidence: 99%
“…Another consideration for the app design is incorporating health information exchange, genomics data integration, complex analysis of patient clinical charts, and other 360 data integration. [16,[35][36][37][38][39] Early diagnosis of ADRD can also benefit disadvantaged populations, such as those with lower socioeconomic and health literacy. [40] Digital inclusion of diverse racial/ethnic disparities is limited and not well represented in existing ADRD research.…”
Section: Artificial Intelligence Can Helpmentioning
confidence: 99%
“…It is believed that utilizing the CDSS under appropriate regulation greatly optimizes patient treatment. To date, the CDSS has been implemented in pharmacology, pharmacogenomics, laboratory medicine, and pathology [ 49 , 50 , 51 , 52 ]. Pregnancy status, renal and hepatic function, drug allergy, drug selection, and dosage for specific diagnostic conditions should be collected.…”
Section: Part 2: Big Data-based Genomic Information Management System...mentioning
confidence: 99%
“…Each parameter, such as drug interaction, chronic disease, and kidney and liver function, is being modeled and refined using patient-derived real-world data [ 53 , 54 , 55 , 56 ]. Recently, as the cost of genomic analysis has decreased and accuracy has improved, genotyping of the cytochrome P450 gene, which encodes a protein that metabolizes drugs with narrow therapeutic windows (e.g., tacrolimus and warfarin), has been included in CDSS [ 50 ]. Based on this, evidence-based drugs and doses will be determined for individual genotypes.…”
Section: Part 2: Big Data-based Genomic Information Management System...mentioning
confidence: 99%
“…38 As a result, the disjointed EHRs and their lack of usability in available CDSS have introduced new medical errors into the health care system. [39][40][41][42][43][44][45] EHR usability and CDSS design remain critical challenge in health care, with implications for medical errors, patient safety, and clinician burnout. 46,47 Current system designers assume that more information supports clinical reasoning and will thus lead to better decisions.…”
Section: Implications For Health It System Designmentioning
confidence: 99%